TDP-43 Proteinopathy and Tauopathy: Do They Have Pathomechanistic Links?

被引:13
|
作者
Riku, Yuichi [1 ,2 ]
Yoshida, Mari [1 ]
Iwasaki, Yasushi [1 ]
Sobue, Gen [3 ]
Katsuno, Masahisa [2 ,4 ]
Ishigaki, Shinsuke [5 ]
机构
[1] Aichi Med Univ, Inst Med Sci Aging, Nagakute 4801195, Japan
[2] Nagoya Univ, Grad Sch Med, Dept Neurol, Nagoya 7448550, Japan
[3] Aichi Med Univ, Grad Sch Med, Nagakute 4801195, Japan
[4] Nagoya Univ, Grad Sch Med, Dept Clin Res Educ, Nagoya 7448550, Japan
[5] Shiga Univ Med Sci, Mol Neurosci Res Ctr, Otsu 5202192, Japan
基金
日本学术振兴会;
关键词
AD; ALS; CBD; FTLD; LATE; PART; PSP; TDP-43; SFPQ; tau; FRONTOTEMPORAL LOBAR DEGENERATION; DNA-BINDING PROTEIN; AMYOTROPHIC-LATERAL-SCLEROSIS; PROGRESSIVE SUPRANUCLEAR PALSY; GRANULOVACUOLAR DEGENERATION; ALZHEIMERS-DISEASE; CORTICOBASAL DEGENERATION; TAU PATHOLOGY; MOUSE MODEL; NEUROPATHOLOGICAL CRITERIA;
D O I
10.3390/ijms232415755
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Transactivation response DNA binding protein 43 kDa (TDP-43) and tau are major pathological proteins of neurodegenerative disorders, of which neuronal and glial aggregates are pathological hallmarks. Interestingly, accumulating evidence from neuropathological studies has shown that comorbid TDP-43 pathology is observed in a subset of patients with tauopathies, and vice versa. The concomitant pathology often spreads in a disease-specific manner and has morphological characteristics in each primary disorder. The findings from translational studies have suggested that comorbid TDP-43 or tau pathology has clinical impacts and that the comorbid pathology is not a bystander, but a part of the disease process. Shared genetic risk factors or molecular abnormalities between TDP-43 proteinopathies and tauopathies, and direct interactions between TDP-43 and tau aggregates, have been reported. Further investigations to clarify the pathogenetic factors that are shared by a broad spectrum of neurodegenerative disorders will establish key therapeutic targets.
引用
收藏
页数:23
相关论文
共 50 条
  • [21] Optogenetic Induction of TDP-43 Proteinopathy In Vivo
    Otte, Charlton
    Mann, Jacob
    Pandey, Udai
    Donnelly, Christopher
    NEUROLOGY, 2019, 92 (15)
  • [22] TDP-43 Proteinopathy Specific Biomarker Development
    Cordts, Isabell
    Wachinger, Annika
    Scialo, Carlo
    Lingor, Paul
    Polymenidou, Magdalini
    Buratti, Emanuele
    Feneberg, Emily
    CELLS, 2023, 12 (04)
  • [23] The basis of clinicopathological heterogeneity in TDP-43 proteinopathy
    Kawakami, Ito
    Arai, Tetsuaki
    Hasegawa, Masato
    ACTA NEUROPATHOLOGICA, 2019, 138 (05) : 751 - 770
  • [24] Glial TDP-43 and TDP-43 induced glial pathology, focus on neurodegenerative proteinopathy syndromes
    Prater, Katherine E.
    Latimer, Caitlin S.
    Jayadev, Suman
    GLIA, 2022, 70 (02) : 239 - 255
  • [25] Identification of TDP-43 modifying kinases in a C. elegans model of TDP-43 proteinopathy.
    Liachko, Nicole F.
    Guthrie, Chris R.
    Kraemer, Brian C.
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2012, 33 : 31 - 32
  • [26] Distinct clinicopathologic clusters of persons with TDP-43 proteinopathy
    Katsumata, Yuriko
    Abner, Erin L.
    Karanth, Shama
    Teylan, Merilee A.
    Mock, Charles N.
    Cykowski, Matthew D.
    Lee, Edward B.
    Boehme, Kevin L.
    Mukherjee, Shubhabrata
    Kauwe, John S. K.
    Kryscio, Richard J.
    Schmitt, Frederick A.
    Fardo, David W.
    Nelson, Peter T.
    ACTA NEUROPATHOLOGICA, 2020, 140 (05) : 659 - 674
  • [27] Distinct clinicopathologic clusters of persons with TDP-43 proteinopathy
    Yuriko Katsumata
    Erin L. Abner
    Shama Karanth
    Merilee A. Teylan
    Charles N. Mock
    Matthew D. Cykowski
    Edward B. Lee
    Kevin L. Boehme
    Shubhabrata Mukherjee
    John S. K. Kauwe
    Richard J. Kryscio
    Frederick A. Schmitt
    David W. Fardo
    Peter T. Nelson
    Acta Neuropathologica, 2020, 140 : 659 - 674
  • [28] Perry's syndrome is a unique TDP-43 proteinopathy
    Wider, C.
    Dickson, D.
    Calne, D.
    Stoessl, J.
    Gutmann, L.
    Calne, S.
    Brown, L.
    Wszolek, Z.
    PARKINSONISM & RELATED DISORDERS, 2007, 13 : S96 - S96
  • [29] Significance and limitation of the pathological classification of TDP-43 proteinopathy
    Arai, Tetsuaki
    NEUROPATHOLOGY, 2014, 34 (06) : 578 - 588
  • [30] ALS and FTLD: two faces of TDP-43 proteinopathy
    Liscic, R. M.
    Grinberg, L. T.
    Zidar, J.
    Gitcho, M. A.
    Cairns, N. J.
    EUROPEAN JOURNAL OF NEUROLOGY, 2008, 15 (08) : 772 - 780